4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-22-055528
EVP, Global Sales & Marketing sold 29,133 shares at an average $6.92 ($201,670)
- EVP, Global Sales & Marketing acquired 29,133 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-01 | Option exercise | +23,429 | $0.84 | $19,680 | 23,429 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-01 | Sale | −23,429 | $6.94 | $162,597 | 0 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-02 | Option exercise | +4,438 | $0.84 | $3,728 | 4,438 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-02 | Option exercise | +1,266 | $1.08 | $1,367 | 5,704 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-02 | Sale | −5,704 | $6.85 | $39,072 | 0 | D |
| Derivatives | |||||||
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-01 | Option exercise · Employee Stock Option (right to buy) | −23,429 | 4,438 | D | ||
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-02 | Option exercise · Employee Stock Option (right to buy) | −4,438 | 0 | D | ||
| Ross Thomas M. EVP, Global Sales & Marketing | 2022-11-02 | Option exercise · Employee Stock Option (right to buy) | −1,266 | 60,734 | D | ||
| Open-market sales · 29,133 sh · avg $6.92 · $201,670 | |||||||
Loading xslF345X03/doc4.xml…